Page 1222 - Adams and Stashak's Lameness in Horses, 7th Edition

1188 Index

farriery (cont’d) diagnosis, 749 intrasynovial anesthesia, 172–174,
175, 176
toe cracks, 1122 etiology, 749 luxation of the metacarpophalangeal/
VetBooks.ir nail abscess, 1131 capital physeal fractures of the femoral clinical signs, 556–557
prognosis, 750
white line disease (WLD), 1123–1124
metatarsophalangeal joint (fetlock
treatment, 749–750
non‐nail alternatives in farriery, 1109–1111
luxation), 556–558
head, 758
indications for glue‐on shoes, 1110
methods of glue‐on farriery, 1110–1111
etiology, 556
diagnosis, 758
puncture wound in the sole, 1131 clinical signs, 758 diagnosis, 557
radiography, 1112 etiology, 758 prognosis, 558
sole bruising, 1129–1130 prognosis, 758 treatment, 557–558
fat‐derived mesenchymal stem cells (MSCs), treatment, 758 magnetic resonance imaging (MRI), 393,
intrasynovial therapies, 891 diaphyseal and metaphyseal femoral 395, 409–415
fatty acids, nutraceuticals, 906 fractures, 740–744 collateral ligament injuries, 415
FDP see fragmentation of the distal patella clinical signs, 740 digital flexor tendon sheath (DFTS)
femoral condyle lesions, 731–734 diagnosis, 740–742 abnormalities, 415
clinical signs, 731–732 etiology, 740 distal sesamoidean ligament injuries,
diagnosis, 731–732 prognosis, 744 412–413
etiology, 731 treatment, 742, 744 frequency of MRI abnormalities,
prognosis, 733 femoral nerve paralysis (crural paralysis), 409–410
treatment, 732, 733 748–749 intersesamoidean ligament injuries, 414
femoral nerve paralysis (crural paralysis), clinical signs, 748 MRI abnormalities, 410–411
748–749 diagnosis, 748 osseous trauma of the proximal phalanx,
clinical signs, 748 etiology, 748 411–412
diagnosis, 748 prognosis, 749 osteoarthritis and articular cartilage
etiology, 748 treatment, 748–749 abnormalities, 414
prognosis, 749 fibrotic and ossifying myopathy, 744–748 osteochondral fragmentation, 414–415
treatment, 748–749 clinical signs, 745 proximal sesamoid bones injuries,
femoropatellar joint diagnosis, 745–746 413–414
see also stifle region etiology, 744–745 subchondral bone abnormalities of the
desmitis of the patellar ligaments, 719–720 treatment, 746–748 metacarpal/metatarsal condyles,
clinical signs, 719–720 palpation and manipulation, 112, 113 410–411
diagnosis, 719–720 partial tear/rupture of the ligament of the suspensory ligament branch injuries, 413
prognosis, 720 head of the femur (round ligament), osteoarthritis of the metacarpophalangeal/
treatment, 720 753–754 metatarsophalangeal joint, 550–552
fragmentation of the distal patella (FDP), clinical signs, 754 clinical signs, 550
716–717 diagnosis, 754 diagnosis, 551
clinical signs, 717 etiology, 754 etiology, 550
etiology, 716–717 prognosis, 754 prognosis, 552
prognosis, 717 treatment, 754 treatment, 552
treatment, 717 quadriceps muscle rupture, 750 osteochondral fractures and fragmentation
functional anatomy, 50–51 third trochanter fractures, 744 of the proximal phalanx, 541–543
intra‐articular fractures: femoral trochlea, trochanteric bursitis (trochanteric clinical signs, 541
714–715 lameness, whirlbone lameness), 750 diagnosis, 541, 542
diagnosis, 714 clinical signs, 750 etiology, 541
etiology, 714 diagnosis, 750 prognosis, 543
prognosis, 714–715 etiology, 750 treatment, 542–543
treatment, 714–715 prognosis, 750 palmar/plantar osteochondral disease,
intra‐articular fractures: patella, 715–716 treatment, 750 552–553
clinical signs, 715 whirlbone lameness, 750 clinical signs, 552
diagnosis, 715 clinical signs, 750 diagnosis, 552–553
etiology, 715 diagnosis, 750 etiology, 552
prognosis, 716 etiology, 750 prognosis, 553
treatment, 715–716 prognosis, 750 treatment, 553
intrasynovial anesthesia, 184 treatment, 750 palpation and manipulation, 97, 98, 99
osteochondritis dissecans (OCD), 711–714, fetlock, 541–560 sesamoiditis, 548–549
1072–1073 see also digit and fetlock clinical signs, 548
clinical signs, 711, 1073 axial osteitis/osteomyelitis of the proximal diagnosis, 548–549
diagnosis, 711–713 sesamoid bones, 549–550 etiology, 548
prognosis, 713–714, 1073 clinical signs, 549–550 prognosis, 549
radiography, 1073 diagnosis, 549–550 treatment, 549
treatment, 713, 1073 etiology, 549 Standardbred racehorses, lameness
patellar luxation/subluxation, 721–722 prognosis, 550 conditions, 966–967, 968
clinical signs, 721 treatment, 550 subchondral cystic lesions (SCLs), 553–554
diagnosis, 721 constriction of or by the fetlock palmar/ clinical signs, 554
etiology, 721 plantar annular ligament (PAL), diagnosis, 554
prognosis, 721–722 558–560 etiology, 553–554
treatment, 721 clinical signs, 558–559 prognosis, 554
upward fixation of the patella (UFP), diagnosis, 559 treatment, 554
717–719 etiology, 558 Thoroughbred racehorses, common
clinical signs, 718 prognosis, 559–560 conditions, 952–954
diagnosis, 718 treatment, 559 traumatic rupture of the suspensory
etiology, 717–718 fractures of the proximal sesamoid bones, apparatus, 554–556
prognosis, 719 543–548 clinical signs, 555
treatment, 718–719 clinical signs, 545–546 diagnosis, 555
femur, 740–759 diagnosis, 546 etiology, 555
see also coxofemoral (hip) joint etiology, 545 prognosis, 555
calcinosis circumscripta (tumoral prognosis, 547–548 treatment, 555
calcinosis), 749–750 treatment, 546–547 fetlock/distal limb/phalangeal flexion,
clinical signs, 749 functional anatomy, 12–13 palpation and manipulation, 115–117